Literature DB >> 1554016

Possible new type of oral-facial-digital syndrome with retinal abnormalities: OFDS type (VIII)

F Gurrieri1, V Sammito, B Ricci, M Iossa, A Bellussi, G Neri.   

Abstract

The most recent classification of the oral-facial-digital syndromes (OFDS) includes 7 types distinguishable by different clinical signs. We describe 2 brothers presenting oral, facial, and digital anomalies and an additional manifestation consisting of specific retinal abnormalities, i.e., retinochoroideal lacunae of colobomatous origin. Our patients may be affected with a new type of OFDS, i.e., OFDS type VIII, characterized by eye abnormalities in addition to other manifestations that partially overlap with those of OFDS type II. Given that there are 2 affected brothers, we cannot distinguish between autosomal and X-linked recessive inheritance.

Entities:  

Mesh:

Year:  1992        PMID: 1554016     DOI: 10.1002/ajmg.1320420608

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  4 in total

Review 1.  Ocular coloboma: a reassessment in the age of molecular neuroscience.

Authors:  C Y Gregory-Evans; M J Williams; S Halford; K Gregory-Evans
Journal:  J Med Genet       Date:  2004-12       Impact factor: 6.318

2.  Oral-facial-digital syndrome type IX in a patient with Dandy-Walker malformation.

Authors:  K Nagai; M Nagao; M Nagao; S Yanai; K Minagawa; Y Takahashi; Y Takekoshi; A Ishizaka; Y Matsuzono; O Kobayashi; T Itagaki
Journal:  J Med Genet       Date:  1998-04       Impact factor: 6.318

Review 3.  Genetics of syndromic ocular coloboma: CHARGE and COACH syndromes.

Authors:  Aman George; Tiziana Cogliati; Brian P Brooks
Journal:  Exp Eye Res       Date:  2020-02-04       Impact factor: 3.467

4.  Growth retardation, intellectual disability, facial anomalies, cataract, thoracic hypoplasia, and skeletal abnormalities: a novel phenotype.

Authors:  Hitesh Shah; Susanne Bens; Almuth Caliebe; John M Graham; Katta Mohan Girisha
Journal:  Am J Med Genet A       Date:  2012-09-17       Impact factor: 2.802

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.